Download as docx, pdf, or txt
Download as docx, pdf, or txt
You are on page 1of 4

CARDIO CENSUS

April 1-7, 2019

Admitting Discharge Date


Service Initials Age/Sex Date Admitted
Diagnosis Diagnosis Discharge
ASHD, CAD, HFrEF
(25%), Ischemic
MAIN MAP 64/M Cardiomyopathy, s/p 04/02/2019 N/A N/A
NSTEMI (2015) in CHF
Class IVD, CAP-MR
CO-Mag
CEB 85/F CAP-MR 04/07/2019 N/A N/A
(Pulmo)
NSTEMI, Stage IIID,
MAIN EPG 66/F 04/03/2019 N/A N/A
CAP-MR
ASHD, CAD, VHD (ASD,
VSD) HF in acute
MAIN ACA 25/F 04/06/2019 N/A N/A
decompensation class
IVD; CAP-MR
CO-MAG
LT 64/F Pulmonary hemorrhage 04/04/2019 N/A N/A
(Pulmo)
CO-MAG
Diabetic Ketoacidosis
(Endo- MLM 53/F 04/02/19 N/A N/A
t/c Pulmonary mass
Neph)
Sepsis secondary to
CO-MAG
FFL 85/M complicated cystitis; 04/02/2019 N/A N/A
(ID)
Prostatitis
CO-MAG
JAP
(Endo- 60/F 04/06/2019 N/A N/A
(Pundaodaya)
Neph)
REFERRAL JGC 60/M CKD St. 5D secondary 03/25/2019 N/A N/A
(Endo- to DKD; Pulmonary
Neph) congestion r/o ACS
Pneumonia in an
REFERRAL
PEM 89/M immunocomprimised 04/02/2019 N/A N/A
(Pulmo)
host
Urosepsis, Acute
Kidney Injury on top of
REFERRAL
Chronic Kidney Disease
(Endo- LST 84/F 04/03/2019 N/A N/A
probably secondary to
Neph)
Hypertensive
Nephrosclerosis
Obstructive Biliary
REFERRAL
LDCE 61/F Disease; Cervical 04/03/2019 N/A N/A
(GI)
Carcinoma Stage IV
REFERRAL
AJD 91/M Infectious Diarrhea 04/05/2019 N/A N/A
(GI)
Hypertensive urgency;
Hypertensive urgency; Breast
Breast Mass, Left likely
Mass, Left likely malignant (T4a
MAIN MTR 47/F malignant (T4a lesion, 03/27/19 04/04/2019
lesion, Cn1, Mx) chemo, RT, SX –
Cn1, Mx) chemo, RT, SX
naïve, SSTI
– naïve, SSTI
UGIB secondary to bleeding
esophageal varices s/p
esophagogastroduodenoscopy
REFERRAL UGIB sec to bleeding with rubber band ligation (april
BC 54/M 03/22/19 04/04/2019
(GI) esophageal varices 2018 x7, nov 2018 x 6, feb 18
2019 x 7); myelofibrosis; liver
cirrhosis secondary to chronic
hepatitis b, not in PSE
REFERRAL AAC 61/F Upper GI Bleeding sec 03/25/19 UGIB secondary to (1.) 04/04/2019
(GI) to Esophageal Varices, Gastroesophageal varices Gov-1; (2.)
Gastric ulcer, fundus s/p EGD (03/22/19)
large, Gastric Polyo,
fundus, Portal
Hypertensive
gastropathy, mild s/p
ECG with RBL, Acute s/p EGD with RBL (04/2018, 11/2018,
Decompensated Liver 02/2019), resolving s/p paracentesis
(03/29/19); Acute Decompensated liver
Cirrhosis, Child Pugh C, cirrhosis secondary to chronic hepatitis
MELD 17, in PSE 1 sec B, Child-Pugh C, MELD 21; not in PSE;
to Chronic Hepatitis B, Myelofibrosis s/p BMA (2013)
Sigmoid CA Stage 2 s/p
Sigmoidectomy, DM
type II, newly
diagnosed
Obstructive Biliary Disease
Secondary to periampullary mass,
probably malignant s/p EGD;
Sepsis secondary to acute
cholangitis; Anemia secondary to
blood loss (tumoral bleed); Sepsis
secondary to acute cholangitis
Obstructive Biliary
secondary to obstructive biliary
REFERRAL Disease secondary to
FRL 49/M 03/30/19 disease; Septic shock secondary 04/02/2019
(GI) choledocholithiasis in
to acute cholangitis secondary to
cholangitis
obstructive biliary disease
secondary to periampullary mass;
Hypovolemia, hyponatremia,
resolved; AKI secondary to septic
shock secondary to cholangitis,
resolving; r/o adrenal
insufficiency
REFERRAL RDP 54/F Obstructive Bile Duct 20 03/31/19 Cholecystolithiasis not in 04/05/2019
to Choledocholithiasis
not in Cholangitis, cholangitis, cholelithiasis in
Cholelithiasis in
(GI) cholecystitis, Hypertension stage
Cholecystitis; HTN
Stage 2, uncontrolled II, controlled
Nasopharyngeal
Carcinoma, Stage IV
REFERRAL
ASP 48/M (Liver mets), Euvolemic 03/31/19 NPCA stage 4A s/p Cisplatin-RT
(HO) hyponatremia
secondary to SIADH
Hepatocellular Carcinoma s/p RFA
(01/31/19, 04Nasopharyngeal CA
Hepatocellular Stage IIB, consider tumor
REFERRAL Carcinoma, early stage
FGM 64/M 04/03/2019 progression, spinal cord 04/03/2019
(GI) s/p RFA (Jan 31, 2019)
– Incomplete Ablation compression T11-T12, ECOG 0;
Constipation, probably neurologic
in etiology/04/19)
ASHD 3V CAD s/p STEMI
ASHD CAD 4 vessel Angiography (2015) NSTEMI,
NSTEMI s/p STEMI Inferior Wall, LVH with segmental
(2015); Acute Respiratory wall abnormality, out of failure,
Failure secondary to
MAIN RFDL 58/F Pulmonary congestion,
04/02/2019 Class IIC, CAP; ARF sec to 04/06/2019
pneumonia; AKI stage III Pulmonary Congestion; AKI stage
secondary to CRS I; DM 3 sec to Cardiorenal Syndrome
type II type 1 of CKD sec to DKD; HTN
Stage II, DM type 2, controlled

You might also like